Avience Biomedicals Limited (NSE:AVIENCE)

Avience Biomedicals Revenue

In the fiscal year ending March 31, 2026, Avience Biomedicals had annual revenue of 525.16M INR with 15.80% growth. Avience Biomedicals had revenue of 122.35M in the quarter ending March 31, 2025. That makes Avience Biomedicals the 39,612th largest company in the world by revenue and 3,752nd in India.

• Revenue: 525.16M
• Revenue Growth: +15.80%
• P/S Ratio: 2.39
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.37B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	525.16M	71.66M	15.80%
Mar 31, 2025	453.50M	213.86M	89.24%
Mar 31, 2024	239.64M	130.38M	119.32%
Mar 31, 2023	109.26M	7.79M	7.68%
Mar 31, 2022	101.48M	90.14M	795.59%

Data Source: S&P Global Market Intelligence Last updated: Jul 23, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error